The FDA approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

Click on this link to read the Official US Food & Drug Administration Press Release :
FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy

The video is courtesy of the All News YouTube channel

Click on this link to visit the New Scientist website to read their post titled: “First cannabis-based drug approved in the US to treat epilepsy”.

Cannabidiol (CBD) is another cannabinoid. Unlike THC, CBD does not produce a high or intoxication. There is some evidence that CBD may block or lower some of the effects of THC on the mind. This may occur when the amount of CBD in the cannabis is the same or higher than the amount of THC. CBD is also being studied for its possible therapeutic uses.

Click on this link to read about
GW Pharmaceuticals plc Epidiolex development